T cell development involves several important processes including rearrangement of the TCR genes, positive selection for MHC restriction, and negative selection against autoreactive clones (1) . Rearrangement of the c~ and 3 chains of the TCR is critical in the generation of a diverse T cell repertoire (2) . Current evidence suggests that the 3 chain alleles are the first to rearrange and do so sequentially (3) . Once a productive rearrangement is achieved, further rearrangement is allelicaUy excluded (4, 5) . By contrast, oe chain rearrangement, which is less well understood, may occur simultaneously (6) and continue to do so until a positive selection signal is received (7) . The less stringent allelic exclusion of the oe chain may account for the finding that some T cell clones express two different c~ chains (1, 6) .
In this report, we raise the issue of multiple ot chain expression by TCR transgenic T cells. Evidence is provided for the in vivo presence of T cells expressing two different c~ chains on their surface. This finding has important implications for experimental systems that utilize TCR transgenic mice.
Materials and Methods
Mice. B10 .BR and transgenic mice were bred at the Walter and Eliza Hall Institute for Medical Research. RIP-K b mice were derived as previously described (8) and were maintained by mating with H-2 k CBA/CaHWehi mice. Des-TCR transgenic mice were the kind gift ofDrs. B. Arnold, G. Sch6nrich and G. J. H~mmer-ling (Deutsches Krebsforschungszentrum, Heidelberg, Germany), and were derived as previously described (9) . The Des-TCR line was maintained by mating with H-2 k B10.BR mice.
Antibodies. The D6sir6 mAb was the kind gift of Dr. A.-M.
Schmitt-Verhulst (Centre d'Immtmologie de Marseille-Luminy, Marseilh, France) (10) . PE-and FITC-conjugated CD8 mAbs were purchased from Becton Dickinson and Co., Mountain View, CA. V region-speeific mAbs B20.1 (anti-V~2) and B20.6 (anti-Va2) were the kind gift of Dr. R Malissen (Centre d'Immunologie de MarseilleLuminy) (11) . RR3-15 (anti-V~11) (12) and KT50 (anti-V~8) (13) mAbs were used as biotinylated mAbs. The GK1.5 mAb was used for staining CD4 + cells (14) . FITC-conjugated sheep anti-mouse Ig was purchased from Silenus Laboratories Pty. Ltd., Hawthorn, Australia.
Flow Cytometry. Two different methods of staining were used.
All incubations were performed on ice in the dark. When cells were stained with only two different mAbs, 5 x 10 s cells were stained with CD8-FITC and the appropriate biotinylated mAb for 30 rain. After two washes, cells were then stained with streptavidin-PE (Caltag Labs., S. San Francisco, CA) for a further 30 rain, washed once, and analyzed. When cells were stained with three different mAbs, 5 x 10 s cells were stained with the appropriate mAb (B20.1, B20.6, or GK1.5) for 30 rain. After two washes, cells were stained with sheep anti-mouse Ig for 30 rain. Cells were then washed twice and exposed to 20/~1 of rat serum for 15 min to block any vacant mouse Ig binding sites on sheep antibodies. This was followed by staining with the appropriate biotinylated TCR-specific mAb (B20.1 or D6sir6) and CDS-PE for 30 min, two washes, and staining with streptavidin conjugated to Tri-color (Caltag Labs.) for 30 rain. After one further wash, cells were analyzed by flow cytometry.
Analysis was performed on a FACScan | (Becton Dickinson and Co.). Live gates were set on lymphocytes by forward and side scatter profiles. Live gates were also set on CD8 § cells, and 10,000 cells were analyzed.
Results and Discussion
Identification of Bimodal Expression of a ~ansgenic TCR. We have been interested in addressing the fate of T ceUs that are specific for antigens expressed outside the thymus. For these studies, we have used the RIP-K b model in which transgenic To examine the fate of Kb-specific T cells in KIP-K b mice, these mice were crossed with TCR transgenic mice (Des-TCK mice) that expressed a transgene encoding a Kb-specific TCK. This receptor could be detected by the clonotype-specific mAb D6sir6 (10) . Flow cytometric analysis of lymph node CD8 + T cells revealed that both single Des-TCK transgenic mice and double Des-TCR x KIP-K b transgenic mice had KLspecific T cells in their periphery ( Fig. 1 and reference 15). Of note, however, was the significant reduction in the number of cells expressing the highest density of the Des-TCK in the double transgenic mice. These analyses highlighted the fact that the CD8 + T cells in the periphery of Des-TCK mice expressed variable levels of the donotypic Des-TCR characterized by a bimodal profile of low and high TCR densities. Des-TCK mice were analyzed on numerous occasions and the bimodal expression was highly reproducible, although the proportion of CD8 + cells that comprised each peak was variable.
CD8 + T Cells Expressing the Lower Density of Des-TCR Express the Transgenic cr Chain.
One explanation for the bimodal expression of the Des-TCK in single transgenic mice was that some cells expressed an endogenous o~ chain, rather than the transgenic c~ chain, paired with the transgenic/3 
Des-TCR
chain. Together these chains may form a new TCK detected with lower affinity by the D6sir6 mAb. To test this, lymph node cells from a Des-TCK mouse were double stained for CD8 and V~2 expression, the latter being the V~ expressed by the transgene (Fig. 2) . Virtually all CD8 + cells expressed the V~2 transgene, and this was expressed with a similar bimodal profile as seen for the Des-TCK. This suggested that those transgenic CD8 + cells expressing the lower density of the Des-TCR also expressed a low density of the transgenic o~ chain.
CD8 + T Cells from Des-TCR Mice Do Not Show Bimoclal Expression of CD3 and the Transgenic /3
Chain. An alternative possibility was that calls expressing the lower density of the Des-TCK might express two different receptors, only one of which could be identified by the D6sir6 mAb. To examine this possibility, Des-TCK transgenic lymph node cells were double stained for CD3 and CD8 (Fig. 3) . This revealed that in contrast to Des-TCK expression, CD3 was expressed as a single peak by lymph node CD8 + T cells. To determine whether the transgenic CD8 + T cells expressed the transgenic/3 chain as a single or double peak, Des-TCK lymph node cells were stained for CD8 and for the transgenic/3 chain V~2 (Fig. 4) . In this case, a biotinylated Vt~2-spedfic mAb was not available, requiring an alternative staining ap- proach. Thus, while control staining for V,2 showed a bimodal peak, it was not as dearly revealed as in Fig. 2 . It is, however, evident that the profile of expression of Va2 is a single peak, as seen for CD3. Thus, CD3 and the Vt~2 transgene were expressed as a single peak, whereas the clonotypic receptor and the V,~2 transgene were expressed in a bimodal manner.
Des-TCR Density Variation Is Due to the Expression of Two ot Chains by Some CD8 + T Cells.
These results suggested that those cells expressing the lower density of the Des-TCR in the Des-TCR transgenic mice may represent cells expressing the transgenic B chain and two c~ chains: one being the transgenic c~ chain and the other endogenously rearranged. To test this possibility, Des-TCR transgenic lymph node cells were triple stained for CD8, the Des-TCR, and V~8 (Fig.  5) . Staining for V~8 was of low intensity, but in control B10.BR mice this method identified a percentage of cells
Des-TCR similar to that previously published (13) (data not shown). Importantly, Des-TCR mice showed a small percentage of CD8+Des-TCR + cells that expressed V~8. In five experiments, an average of 4.1 _+ 0.8% ofCDS+Des-TCR + cells expressed V~8. When the CD8 + V~8 + cells were examined for Des-TCR expression, these cells were found to be included in the population of cells expressing the lower density of the Des-TCR (Fig. 6) . Furthermore, the mean intensity of V~8 on Des-TCK + cells was found to be half that of normal B10.BR cells (mean fluorescence intensity of 41.5 vs. 84.2). Triple staining for CD8, V~2 and V~8 revealed that some cells expressed both V~2 and V~8 (Fig. 7) . Together these data showed that Des-TCR transgenic mice possess CD8 + T cells that express different densities of the Des-TCR, of which at least some of those expressing the lower density also express an endogenous ot chain on their surface. Potential Consequences of the Expression of Two cr Chains. To our knowledge, this finding represents the first demonstration that in vivo cells can express two different types of TCK on the surface of the same cell. Whether such cells are also present in normal T cell repertoires must await further analysis. These findings have extremely important implications for at least two areas that utilize TCK transgenic mice. First, when addressing the various haplotypes that positively select a given TCR transgene, the endogenous expression of an ot chain together with the transgenic o~ chain could lead to false conclusions. In situations where the transgenic receptor cannot receive a positive selection signal, T cells may be positively selected by their nontransgenic receptor. T cells bearing the transgenic receptor would enter the periphery of these mice, leading to the false conclusion that positive selection had occurred via this receptor.
The second, and more major consequence of expressing two c~ chains is that such T cells may have two completely different antigen specificities. This is particularly relevant to autoimmunity studies. We recently reported the induction of autoimmune diabetes in transgenic mice coexpressing three different transgenes, the Des-TCR, RIP-K b, and KIP-IL-2 (IL-2 expressed by the pancreatic/3 cells) (15) . In some mice, diabetes was induced as early as 7 d after birth. Since the CD8 + T cells in these triple transgenic mice expressed the lower density of the Des-TCR, due to the thymic deletion of those cells expressing the higher density (15) , it is likely that they also expressed a second TCK comprised of the transgenic/3 chain and an endogenous ot chain. Since naive T cells do not express IL-2 receptors, and do not usually infiltrate tissues (16) , it was unclear how these Kb-specific cells were initially activated so that they could respond to IL-2 and destroy islet tissue. How they were attracted to the islets without expressing IL-2 receptors is still unresolved. While it is possible that these cells were attracted by secondary lymphokines induced as a consequence of IL-2 synthesis, the likely expression of two receptors raises an alternative possibility. These cells may have been activated via recognition of an environmental antigen by their endogenously derived TCR and, after activation, responded to IL-2 produced by the islet/3 cells and caused Kb-specific destruction via their transgenic TCR.
This scenario may be applicable to several other models. Recently, aft transgenic nonobese diabetic mice were shown to be susceptible to autoimmune diabetes despite their expression of a transgenic TCK with no specificity for islet antigens (17) . In this study, the expression of endogenously rearranged ot chains was not examined. Such c~ chains may have combined with the transgenic/3 chain to produce a broad repertoire still capable of causing specific autoimmunity.
It has also been reported that TCR transgenic mice specific for myelin basic protein developed spontaneous autoimmunity, but that this varied depending on the animal housing facility (18) . This might be explained if two receptors were expressed by the transgenic T cells. Once these cells responded to an environmental antigen via their endogenously rearranged TCK, they may have caused autoimmunity via their transgenic TCK. This would explain why animal facilities possessing a greater number of pathogens were more likely to be associated with autoimmunity.
Relevance to Autoimmunity. These findings question the view that stimulation by a cross-reactive environmental antigen is required for the induction of autoimmunity. Analysis of T cell clones has revealed that T cells from normal repertoires can express two productively rearranged ~ chains (3). In these examples, however, only one o~ chain was detected on the cell surface. Due to the low frequency of any one o~ chain in a normal repertoire, and the limited range of ol chain-specific mAbs available, demonstration of cells expressing two c~ chains on their surface is technically difficult. If a certain proportion of T cells do express two rearranged c~ chains on their surface, it is possible that T cells bearing autoreactive TCR may be activated to cause autoimmunity via recognition of an environmental antigen by their second, nonautoreactive TCK. In this case, no molecular mimicry would be required. The frequency of such cells among T cells bearing two different TCK is, however, likely to be very low. Since, of the two TCK, the autoreactive receptor would, by definition, be MHC restricted, there would be no requirement for MHC restriction of the second receptor; positive selection in the thymus could occur via the autoreactive receptor. The likelihood that the second receptor would recognize an environmental antigen in an MHC-restricted manner would, therefore, depend on the innate frequency of MHCrestriction of TCRs. This might be increased somewhat by the presence ofa fl chain that is able to form an MHC-restricted receptor.
While it remains unclear whether the presence of T cells expressing two TCK clonotypes is applicable to a normal T cell repertoire, we have provided direct evidence that transgenic T cells may possess this phenotype in vivo. Future experiments may clarify the importance of this finding to autoimmunity.
